Fenbendazole has been extensively studied as a veterinary anthelmintic. Animal and parasitological studies demonstrate activity against a range of roundworms and certain other helminths, forming the basis for its established veterinary use.
The evidence for human use is substantially different. There is not sufficient clinical evidence to establish fenbendazole as a standard, broadly approved treatment for human helminth infections. Consequently, claims that fenbendazole is an established treatment for cancer or other non-parasitic diseases should not be presented as proven medical indications.
Researchers have also investigated fenbendazole because of its effects on cellular microtubules and its potential activity in experimental cancer models. However, these findings do not demonstrate that fenbendazole is an effective cancer treatment in humans and should not replace approved oncology treatment.
Fenbendazole is primarily used as an anthelmintic in veterinary medicine for certain parasitic infections.
Its mechanism involves disruption of parasite microtubule function, interfering with essential metabolic processes and ultimately impairing parasite survival.
Susceptible organisms may include certain roundworms, such as ascarids, hookworms, and whipworms, as well as selected tapeworm species. Activity depends on the parasite and host species.
For human use, the medication should not be self-administered for presumed worm infections; identification of the causative organism and professional medical assessment are recommended.
The tablets are taken orally. The appropriate regimen depends on the parasite species, body weight, animal species, and the specific veterinary or medical treatment protocol. The dose should not be determined independently based only on the amount of active ingredient contained in a tablet. Human use requires consultation with a healthcare professional because fenbendazole does not have the same established evidence base for human infections as it does for veterinary applications.
If severe or unusual symptoms occur, use should be discontinued and professional medical advice should be sought.
